-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Moderna recently stated that it has produced an updated version of the COVID-19 vaccine, which is designed to better protect against the B.
The vaccine candidate for COVID-19, known as mRNA-1273.
Moderna said it plans to evaluate the other two enhance the immune methods of force, in order to enhance immunity to resist SARS-CoV-2 mutation.
immunity
In addition to this strengthening strategy, the company also stated that it plans to use mRNA-1273.
In addition, Moderna said it will evaluate the immunogenicity and safety of mRNA-1273.
Original source:
Original source:https://target="_blank" rel="noopener">https:// style="vertical-align: inherit;"> https:// leave a message here